Biosurgery Market

The report "Biosurgery Market by Product (Bone Graft Substitutes, Sealants (Natural (Gelatin, Collagen)), Hemostatic Agents, Soft-tissue Attachments (Synthetic, Biological)), Application (Orthopedic, Urological), End User (Hospitals, ASCs) - Global Forecast to 2030" is projected to reach USD 21.59 billion by 2030 from USD 15.83 billion in 2025, at a CAGR of 6.4% from 2025 to 2030.

Browse 502 market data Tables and 61 Figures spread through 413 Pages and in-depth TOC on "Biosurgery Market - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/biosurgery-market-166922302.html

The global surge in surgical procedures is significantly propelling the demand for biosurgery products. The escalation in elective surgeries can be primarily linked to the rising incidence of obesity and lifestyle-related diseases, an aging population, an increased prevalence of orthopedic disorders, and a higher rate of spinal injuries and sports-related traumas. Biosurgery products are particularly crucial in managing severe trauma cases, including traumatic brain injuries (TBIs), spinal cord injuries, vertebral fractures, tension pneumothorax, and subarachnoid hemorrhages. A growing emphasis on effective hemostatic management during surgical interventions further fuels the demand for biosurgical products such as hemostatic agents and surgical sealants and adhesives. In addition, established market players are significantly investing in research and development to enhance their competitive positioning, which has led to an influx of advanced biosurgical products into the marketplace.

By product, surgical sealants and adhesives segment is expected to grow at the highest CAGR during the forecast period.

By products, the biosurgery market is segmented into bone-graft substitutes, soft-tissue attachments, hemostatic agents, surgical sealants and adhesives, adhesion barriers, and staple-line reinforcement agents. The surgical sealants and adhesives segment is anticipated to exhibit the most rapid growth within the biosurgery market during the forecast period. This sector's expansion is largely attributed to a significant shift from conventional wound closure techniques, such as sutures and staples, towards more sophisticated closure strategies that yield superior clinical outcomes. Surgical sealants and adhesives facilitate the natural healing process by promoting effective tissue adhesion, reducing fluid leakage, decreasing operative times, and minimizing postoperative complications. A pivotal factor driving this growth is the global shift toward the utilization of natural and biocompatible sealants, particularly fibrin-based formulations, which are favored for their high biocompatibility, user-friendly application, and low risk of infection. The rising demand for minimally invasive surgical procedures, especially in fields such as cardiovascular, neurological, and general surgery, has led to an increased reliance on these products to enhance surgical efficiency and improve patient safety. Additionally, ongoing research and development are yielding next-generation synthetic and hybrid formulations that promise enhanced adhesion properties, quicker setting times, and wider applicability across various tissue types. This convergence of clinical demand, technological innovation, and improved safety profiles is propelling the swift growth of the surgical sealants and adhesives sector within the broader biosurgery market.

By application, the reconstructive surgery segment is expected to grow at the highest CAGR during the forecast period.

Based on applications, the biosurgery market is segmented into orthopedic surgeries, general surgeries, neurological surgeries, cardiovascular surgeries, reconstructive surgeries, gynecological surgeries, urological surgeries, thoracic surgeries, and other surgical applications. The reconstructive surgeries segment is projected to be the most rapidly expanding area within the biosurgery market during the forecast period, primarily fueled by an increase in both medically indicated and elective procedures. Key factors contributing to this growth include the rising incidence of facial cosmetic surgeries, a higher prevalence of skin and burn injuries, and an increasing number of breast cancer survivors opting for reconstructive surgery post-mastectomy. Significant advancements in surgical methodologies, along with the development of biosurgical products such as hemostatic agents, tissue sealants, and soft tissue reinforcement materials, are markedly improving surgical precision, accelerating recovery times, and enhancing both aesthetic and functional outcomes in reconstructive interventions. Data from the Global Survey by ISAPS indicate that over 14.9 million surgical cosmetic procedures were undertaken globally in 2022, representing an 11.2% increase compared to the previous year. This trend underscores a growing patient inclination towards aesthetic enhancement and reconstructive interventions. Moreover, the rising acceptance of minimally invasive techniques in both cosmetic and reconstructive surgery, alongside the aging demographic's increasing interest in restorative procedures, further bolsters the rapid expansion of this segment. Consequently, the demand for biosurgical products specifically designed for reconstructive applications is anticipated to increase significantly.

North America commanded the largest share in the global biosurgery market in 2024.

The biosurgery market is segmented into five major regional segments: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, North America is poised to retain the largest share of the global biosurgery market, largely driven by the high incidence of chronic diseases necessitating surgical interventions, including cardiovascular, neurological, and oncological conditions. According to the CDC, as of October 2024, 60% of Americans are affected by at least one chronic disease, and 40% are living with two or more. These health challenges often lead to complex surgical procedures where biosurgical products—such as hemostats, sealants, adhesion barriers, and soft tissue repair agents—play a crucial role in minimizing complications and improving patient outcomes. The region benefits from a robust healthcare infrastructure, supportive reimbursement frameworks, and the presence of industry leaders such as Baxter International Inc., Johnson & Johnson, and Stryker Corporation, among others. Additionally, North America's significant investment in research and development, along with a propensity for early adoption of advanced surgical technologies, ensures a consistent influx of innovative biosurgical solutions. The increasing establishment of ambulatory surgical centers and ongoing hospital expansions, rising surgical volumes, and enhanced awareness among healthcare providers further solidify North America's dominance in the biosurgery market. This multifaceted landscape facilitates the continuous evolution and availability of sophisticated biosurgical products that address the needs of an aging population and a growing number of surgical procedures.

Some of the prominent players operating in the market include market Medtronic (Ireland), Johnson & Johnson Services, Inc. (US), Baxter (US), Becton, Dickinson and Company (BD) (US), B. Braun SE (Germany), Stryker (US), Integra Lifesciences Holdings Corporation (US), CSL Ltd. (Australia), Hemostasis LLC (US), and Pfizer Inc. (US), among others.

Don’t miss out on business opportunities in Biosurgery Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/